The Learning Portal will be under maintenance Saturday, 8 August between 6 AM and 6 PM EST. Portal functionality will be unavailable during this window.
We apologize for any inconvenience caused during this time.

RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
Regulatory Focus™ > News Articles > In Focus: Advertising, Labeling & Promotion

In Focus: Advertising, Labeling & Promotion

Posted 01 November 2009 | By

A two-day FDA public meeting on social media… Issuance of two FDA guidance documents relating to Good Reprint Practices and presentation of risk information in prescription drug and medical device promotion… A legal challenge to FDA's policies on off-label promotion… An increase in FDA enforcement letters relating to product promotion, with more likely to come… Yes, advertising and promotion remains a hot regulatory topic, with more activity to come.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe